SWTX — SpringWorks Therapeutics Share News
0.000.00%
Last trade - 00:00- $3.54bn
- $3.25bn
- $191.59m
Brief: Rappta Therapeutics Enters Into A Global License Agreement With Springworks Therapeutics
U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart
SpringWorks Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Canadian National Railway, C.H. Robinson, Meta
U.S. STOCKS ON THE MOVE-Honeywell, Canadian National Railway, C.H. Robinson
SpringWorks Therapeutics falls on third-quarter revenue miss
Brief: SpringWorks Therapeutics to Present Phase 3 DeFi Trial Data of Ogsiveo in Desmoid Tumors at CTOS 2024 Meeting
SpringWorks rises as FDA grants priority review to genetic disorder drug
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
SpringWorks Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify
SpringWorks rises on Q2 revenue beat
SpringWorks Therapeutics Inc expected to post a loss of $1.11 a share - Earnings Preview
Brief: Springworks Therapeutics Completes Submission Of New Drug Application To The FDA For Mirdametinib
U.S. RESEARCH ROUNDUP-Biontech, Honeywell International, Klaviyo
Brief: Springworks Got Notice Of Termination Of Amended & Restated Collaboration And License Agreement Between Co & GSK
SpringWorks Therapeutics Inc reports results for the quarter ended in March - Earnings Summary